Is Alterity Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ATHE) stock is to Strong Buy ATHE stock.
Out of 2 analysts, 2 (100%) are recommending ATHE as a Strong Buy, 0 (0%) are recommending ATHE as a Buy, 0 (0%) are recommending ATHE as a Hold, 0 (0%) are recommending ATHE as a Sell, and 0 (0%) are recommending ATHE as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year ATHE price target, the average ATHE price target is $13.00, with the highest ATHE stock price forecast at $16.00 and the lowest ATHE stock price forecast at $10.00.
On average, Wall Street analysts predict that Alterity Therapeutics's share price could reach $13.00 by Jun 30, 2027. The average Alterity Therapeutics stock price prediction forecasts a potential upside of 120.71% from the current ATHE share price of $5.89.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.